AstraZeneca PLC (AZN) stock forecast · P/E 28, $288.38B cap
AstraZeneca PLC (AZN) is a drug manufacturers - general company listed on US.
This AZN forecast page states what the cached financials imply — not a price target and not a guarantee. AstraZeneca PLC outlooks on Lician start from reported revenue and the latest filing, then you decide.
No cached income statement for AZN yet, so there is no numeric 2026 base to extend.
Period-over-period revenue change is not in cache for AZN, so this page does not invent a growth rate.
AZN currently screens at market cap $288.38B and trailing P/E 28.0. Stretching today's multiple into 2026 without a filing reason is how thin forecast pages get ignored.
When the next AZN 10-Q or 8-K lands, this outlook should move. Until then the SEC page is the source.
Not a prediction market. For the live quote and the full model, use the AZN stock page.
Not investment advice.